Catherine T. Doherty - Mar 7, 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Signature
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Catherine T. Doherty
Stock symbol
DGX
Transactions as of
Mar 7, 2022
Transactions value $
-$36,004
Form type
4
Date filed
3/9/2022, 03:40 PM
Previous filing
Feb 28, 2022
Next filing
Nov 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Award $1.74M +13.4K +19.77% $130.09 81.1K Mar 7, 2022 Direct F1
transaction DGX Common Stock Tax liability -$827K -6.36K -7.84% $130.09 74.8K Mar 7, 2022 Direct F2
transaction DGX Common Stock Sale -$951K -7.03K -9.41% $135.21 67.7K Mar 8, 2022 Direct F3
holding DGX Common Stock 4.16K Mar 7, 2022 401(k)/SDCP F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d).
F2 Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
F3 The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.
F4 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.